First DataBank divests Medi-Span
Executive Summary
Hearst subsidiary First DataBank sells Medi-Span business to Wolters Kluwer's Facts and Comparisons as part of a proposed settlement with the Federal Trade Commission Nov. 9. Under the settlement, First DataBank customers can terminate their contracts for National Drug Data File products. In April, FTC filed a complaint against Hearst in D.C. federal court alleging that Hearst had monopolized the integrated drug information database market via its acquisition of Medi-Span (1"The Pink Sheet" April 9, p. 6)...
You may also be interested in...
First DataBank Must Create Integratable Data Files Competitor, FTC Says
First DataBank would be required to set up a competitor in the integratable drug data file market under an April 4 FTC complaint regarding the 1998 acquisition of Medi-Span by Hearst, which also owns First DataBank.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.